cRGD-conjugated magnetic-fluorescent liposomes for targeted dual-modality imaging of bone metastasis from prostate cancer

Journal of Liposome Research

Volumn 25, Issue 2, 2015, Pages 89-100

  Wang, Fangfang ^a   Chen, Zhongping ^a   Zhu, Li ^a  

^a NANTONG UNIVERSITY   (China)

Author keywords

Bone metastasis; Dual modality imaging; Iron oxide nanoparticles; Liposome; Quantum dots; RGD peptide

Indexed keywords

CADMIUM; CYCLIC ARGINYLGLYCYLASPARTYLTYROSYLLYSINE PEPTIDE; IRON OXIDE; LIGAND; LIPID; LIPOSOME; MACROGOL; OLEIC ACID; QUANTUM DOT; SELENIUM; SUCCIMER; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; ARGINYL-GLYCYL-ASPARTIC ACID; CADMIUM DERIVATIVE; CADMIUM SELENIDE; FLUORESCENT DYE; MAGNETITE NANOPARTICLE; OLIGOPEPTIDE; SELENIUM DERIVATIVE;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METASTASIS; CONTROLLED STUDY; CYTOTOXICITY; FLUORESCENCE IMAGING; IN VITRO STUDY; LIVER; MACROPHAGE; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHAGOCYTOSIS; PHOSPHOLIPID BILAYER; PRIORITY JOURNAL; PROSTATE CANCER; ROOM TEMPERATURE; SIGNAL DETECTION; BONE NEOPLASMS; CHEMISTRY; DIAGNOSTIC IMAGING; HUMAN; MAGNETISM; MALE; PROSTATIC NEOPLASMS; SECONDARY;

BONE NEOPLASMS; CADMIUM COMPOUNDS; DIAGNOSTIC IMAGING; FLUORESCENT DYES; HUMANS; LIPOSOMES; MAGNETIC PHENOMENA; MAGNETITE NANOPARTICLES; MALE; OLIGOPEPTIDES; PROSTATIC NEOPLASMS; QUANTUM DOTS; SELENIUM COMPOUNDS;

EID: 84942869658     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.3109/08982104.2014.928890     Document Type: Article

References (52)

1. Ahsan F, Rivas IP, Khan M.A., et al. (2002). Targeting to macrophages: role of physicochemical properties of particulate carriers - liposomes and microspheres - on the phagocytosis by macrophages. J Control Release 79:29-40.
2. Al-Jamal W.T., Al-Jamal KT, Bomans P.H., et al. (2008). Functionalized-quantum-dot-liposome hybrids as multimodal nanoparticles for cancer. Small 4:1406-15.
3. Al-Jamal W.T., Kostarelos K. (2011). Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc Chem Res 44:1094-104.
4. Bai J, Zhou ZY, Tang H.L., et al. (2013). Impact of PEGylation on biodistribution and tumor accumulation of Lipid-Mu peptide-DNA. J Liposome Res 23:1-10.
5. Beaune G, Dubertret B, Clement O., et al. (2007). Giant vesicles containing magnetic nanoparticles and quantum dots: feasibility and tracking by fiber confocal fluorescence microscopy. Angew Chem Int Ed 46:5421-4.
6. Berret JF, Schonbeck N, Gazeau F., et al. (2006). Controlled clustering of superparamagnetic nanoparticles using block copolymers: design of new contrast agents for magnetic resonance imaging. J Am Chem Soc 128:1755-61.
7. Cai WB, Yang XQ, Hong H, et al (2011). cRGD-functionalized, DOX-conjugated, and (64)Cu-labeled superparamagnetic iron oxide nano-particles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 32:4151-60.
8. Cao J, Zhu HY, Deng D.W., et al. (2012). In vivo NIR imaging with PbS quantum dots entrapped in biodegradable micelles. J Biomed Mater Res A 100A:958-68.
9. Chen H, Li B, Ren X., et al. (2012). Multifunctional near-infrared-emitting nano-conjugates based on gold clusters for tumor imaging and therapy. Biomaterials 33:8461-76.
10. Chen ZP, Zhang Y, Xu K., et al. (2008a). Stability of hydrophilic magnetic nanoparticles under biologically relevant conditions. J Nanosci Nanotechnol 8:6260-5.
11. Chen ZP, Zhang Y, Zhang S., et al. (2008b). Preparation and characterization of water-soluble monodisperse magnetic iron oxide nanopar-ticles via surface double-exchange with DMSA. Colloids Surf A 316: 210-16.
12. Chiu CF, Dementev N, Borguet E. (2011). Fluorescence quenching of dyes covalently attached to single-walled carbon nanotubes. J Phys Chem A 115:9579-84.
13. Costelloe CM, Rohren EM, Madewell J.E., et al. (2009). Imaging bone metastases in breast cancer: techniques and recommendations for diagnosis. Lancet Oncol 10:606-14.
14. Ding JL, Wang YH, Ma M, et al (2013). CT/fluorescence dual-modal nanoemulsion platform for investigating atherosclerotic plaques. Biomaterials 34:209-16.
15. El Mouedden M., Meert TF (2005). Evaluation of pain-related behavior, bone destruction and effectiveness of fentanyl, sufentanil, and morphine in a murine model of cancer pain. Pharmacol Biochem Behav 82:109-19.
16. Fang C, Shi B, Pei Y-Y, et al. (2006). In vivo tumor targeting of tumor necrosis factor-α-loaded stealth nanoparticles: effect of MePEG molecular weight and particle size. Eur J Pharm Sci 27:27-36.
17. Fattahi H, Laurent S, Liu F.J., et al. (2011). Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics. Nanomedicine 6:529-44.
18. Glendenning J, Cook G. (2013). Imaging breast cancer bone metastases: current status and future directions. Semin Nucl Med 43:317-23.
19. Ho D, Sun X, Sun S. (2011). Monodisperse magnetic nanoparticles for theranostic applications. Acc Chem Res 44:875-82.
20. Hodenius M, Wurth C, Jayapaul J., et al. (2012). Fluorescent magnetoliposomes as a platform technology for functional and molecular MR and optical imaging. Contrast Media Mol Imaging 7: 59-67.
21. Huang J, Zhong X, Wang L., et al. (2012). Improving the magnetic resonance imaging contrast and detection methods with engineered magnetic nanoparticles. Theranostics 2:86-102.
22. Josephson L, Kircher MF, Mahmood U, et al (2002). Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 13:554-60.
23. Kuang Y, Liu J, Liu Z.L., et al. (2012). Cholesterol-based anionic long-circulating cisplatin liposomes with reduced renal toxicity. Biomaterials 33:1596-606.
24. Lee N, Hyeon T. (2012). Designed synthesis of uniformly sized iron oxide nanoparticles for efficient magnetic resonance imaging contrast agents. Chem Soc Rev 41:2575-89.
25. Lipton A, Cook R, Saad F., et al. (2008). Normalization of bone markers is associated with improved survival in patients with bone metastases from solid tumors and elevated bone resorption receiving zoledronic acid. Cancer 113:193-201.
26. Liu DF, Wu W, Chen X., et al. (2012a). Conjugation of paclitaxel to iron oxide nanoparticles for tumor imaging and therapy. Nanoscale 4: 2306-10.
27. Liu P, Qin L, Wang Q., et al. (2012b). cRGD-functionalized mPEG-PLGA-PLL nanoparticles for imaging and therapy of breast cancer. Biomaterials 33:6739-47.
28. Liu DF, Wu W, Ling J.J., et al. (2011). Effective PEGylation of iron oxide nanoparticles for high performance in vivo cancer imaging. Adv Funct Mater 21:1498-504.
29. Mulder WJM, Griffioen AW, Strijkers G.J., et al. (2007). Magnetic and fluorescent nanoparticles for multimodality imaging. Nanomedicine 2:307-24.
30. Mundy GR. (2002). Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2:584-93.
31. Muthu MS, Kulkarni SA, Raju A, et al (2012). Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots. Biomaterials 33:3494-501.
32. Nie Y, Ji L, Ding H., et al. (2012). Cholesterol derivatives based charged liposomes for doxorubicin delivery: preparation, in vitro and in vivo characterization. Theranostics 2:1092-103.
33. Park J, An KJ, Hwang Y.S., et al. (2004). Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 3:891-5.
34. Pearce T, Philip S, Brown J., et al. (2012). Bone metastases from prostate, breast and multiple myeloma: differences in lesion conspicuity at short-tau inversion recovery and diffusion-weighted MRI. Br J Radiol 85:1102-6.
35. Poselt E, Schmidtke C, Fischer S., et al. (2012). Tailor-made quantum dot and iron oxide based contrast agents for in vitro and in vivo tumor imaging. ACS Nano 6:3346-55.
36. Reischauer C, Froehlich JM, Koh D-M, et al. (2010). Bone metastases from prostate cancer: assessing treatment response by using diffusion-weighted imaging and functional diffusion maps - initial observations. Radiology 257:523-31.
37. Rosen JE, Chan L, Shieh D.B., et al. (2012). Iron oxide nanoparticles for targeted cancer imaging and diagnostics. Nanomed Nanotechnol 8: 275-90.
38. Sadzuka Y, Kishi K, Hirota S., et al. (2003). Effect of polyethyleneglycol (PEG) chain on cell uptake of PEG-modified liposomes. J Liposome Res 13:157-72.
39. Samokhvalov PS, Artemyev MV, Nabiev IR (2013). Current methods of the synthesis of luminescent semiconductor nanocrystals for biomedical applications. Nanotechnol Russia 8:409-22.
40. Selvan ST, Patra PK, Ang C.Y., et al. (2007). Synthesis of silica-coated semiconductor and magnetic quantum dots and their use in the imaging of live cells. Angew Chem Int Ed 46:2448-52.
41. Snoeks TJ, Van Beek E, Que I, et al (2012). Bioluminescence imaging of bone metastasis in rodents. Methods Mol Biol 816:507-15.
42. Song EQ, Hu J, Wen C.Y., et al. (2011). Fluorescent-magnetic-biotargeting multifunctional nanobioprobes for detecting and isolating multiple types of tumor cells. ACS Nano 5:761-70.
43. Stefanick JF, Ashley JD, Kiziltepe T, et al (2013). A systematic analysis of peptide linker length and liposomal polyethylene glycol coating on cellular uptake of peptide-targeted liposomes. ACS Nano 7:2935-47.
44. Sun P, Zhang HY, Liu C, et al (2010). Preparation and characterization of Fe(3)O(4)/CdTe magnetic/fluorescent nanocomposites and their applications in immuno-labeling and fluorescent imaging of cancer cells. Langmuir 26:1278-84.
45. Swierczewska M, Lee S, Chen XY (2011). The design and application of fluorophore-gold nanoparticle activatable probes. Phys Chem Chem Phys 13:9929-41.
46. Tian ZQ, Zhang ZL, Gao J.H., et al. (2009). Color-tunable fluorescent-magnetic core/shell multifunctional nanocrystals. Chem Commun 27:4025-7.
47. Wang RR, Xiao RZ, Zeng Z.W., et al. (2012). Application of poly(ethyl-ene glycol)-distearoylphosphatidylethanolamine (PEG-DSPE) block copolymers and their derivatives as nanomaterials in drug delivery. Int J Nanomed 7:4185-98.
48. Wang XH, Cai LL, Zhang X.Y., et al. (2011). Improved solubility and pharmacokinetics of PEGylated liposomal honokiol and human plasma protein binding ability of honokiol. Int J Pharm 410: 169-74.
49. 4 nanoparticles for reduced non-specific uptake by macrophage cells. Adv Mater 19:3163-6.
50. Yu WW, Peng XG (2002). Formation of high-quality CdS and other II-VI semiconductor nanocrystals in noncoordinating solvents: tunable reactivity of monomers. Angew Chem Int Ed 41:2368-71.
51. Zheng Q, Fang D, Cai J., et al. (2012). Enhanced excitability of small dorsal root ganglion neurons in rats with bone cancer pain. Mol Pain 8:24-42.
52. Zrazhevskiy P, Sena M, Gao XH (2010). Designing multifunctional quantum dots for bioimaging, detection, and drug delivery. Chem Soc Rev 39:4326-54.